Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Role of Folate and DHA in Preterm Delivery Prevention. 1 What is the right suplemntation? Folic Acid Niacin B1 DHA Iron Ca B6 B2 Zinc Iodine Biotin B12 Vit C Vit E 2 Prevalence data in Iran • The prevalence of NTDs at birth varies considerably by country, geographic zone, ethnic and racial group; it ranges from as high as 1 case in 100 births in some regions of China to about 1 case in 2000 or less in some Scandinavian countries. In many countries the prevalence is approximately 1 in 1000 births 2 • Previous studies on NTDs have been carried out in some parts of the Islamic Republic of Iran. In Tehran (1969–78), 1.76/1000 new born had NTDs. In Hamadan (1991–97) 5.1/1000 and In Kordestan 5.5/1000 new born had NTDs 2 • Between 1998 and 2003. The prevalence at birth of NTDs during the 6-year period was therefore 2.87 per 1000 births 2 1. 2. Verma, I. C. High frequency of neural tube defects in North India. Lancet 1, 879–880 (1978). La Revue de Sante de la Mediterranee orientale, Vol. 13, N3, 2007 3 Let start with folic acid!!!! Folate? Folic acid? Metafolin??? 4 Terminology is a basic(Clinic Pharmacokinet, 2010, AJCN, 2010, REVIEWS IN OBSTETRICS & GYNECOLOGY, 11) Dietary folate: Naturally occurring nutrient found in foods such as leafy green vegetables, legumes, egg yolk, liver, and citrus fruit Folate: Generic of grouprelated compounds • Essential vit • Diet/supp Folic acid • Synthetic • Enriched food/pharma vit Metafolin • LMTHF (LMethylfolate) • Active folate form (FADHF-THF- LMF) • Plasma/active MTHFR main in biological processes 5 What is Metafolin®? Metafolin® is the calcium salt of the biologically active form of folate 5-MTHF. Metafolin® dissociates into calcium and the biologically active folate form 5-MTHF, the main folate form in maternal and cord blood. Unlike folic acid, Metafolin® is directly available without metabolisation. Metafolin® is particularly useful in women who cannot optimally metabolise folic acid due to the MTHFR C677T polymorphism. 6 T enzyme polymorphism • The methylenetetrahydrofolate reductase (MTHFR) 677C˃T polymorphism is a risk factor for neural tube defects. • The T allele produces an enzyme with reduced folate-processing ability. • The prevalence of the MTHFR 677TT genotype varies across ethnic groups and regions, ranging from: • < 2% in West African and American populations18,19 to • ˃ 35% in northern Chinese and individuals of Mexican decent.18-20 • ≈ 50% in Europe • Meta-analysis data has shown that mothers or infants with the TT genotype are at greated odds of having a pregnancy affected by an NTDs than do those with the CC genotype.21-23 homozygous TT: heterozygous CT: wildtype CC: Enzyme activity reduced by approx. 70% Enzyme activity reduced by approx. 30% Enzyme activity not reduced 18Gue´ant-Rodriguez RM, et al. Am J Clin Nutr 2006; 83:701–7. LD, Yang Q. Am J Epidemiol 2000; 151:862–77. S, Wilson RB. J Hum Genet 2003; 48:1–7. 21Yan L, et al. PLoS ONE 2012; 7:e41689. 22Zhang T, et al. PLoS ONE 2013; 8:e59570. 23Yadav U, et al. Metab Brain Dis 2015; 30(1):7–24. 19Botto 20Ogino 7 Metafolin® – ME MTHFR polymorphism "Geographical and ethnic variation of the 677C>T allele of 5,10 methylenetetrahydrofolate reductase (MTHFR): findings from over 7000 new-borns from 16 areas world wide" Region ME CC 57% CT 34% J Med Genet 2003;40:619–625 TT 8% 8 J Obstet Gynaecol Can 2015;37(6):534–549 Title of Presentation | DD.MM.YYYY 9 DHA Docosahexaenoic acid DHA supply to the foetus and infant DHA content in forebrains of fetuses & infants (n=34, preterm and postnatal up to 2 years) From approx. the 22nd week of pregnancy there is a rapid brain growth and large amounts of DHA need to be deposited in the child’s growing tissues, which depends on maternal DHA supply. Placebo-controlled study during lactation: DHA content of breast milk increased up to 90% with DHA supplementation whereas the DHA content in the control group decreased by 17%. • 25Adapted from Serhan CN, et al. Annu Rev Pathol 2008; 3:279–312. 33Koletzko 35Jensen B, et al. Acta Paediatr. 2011; 100:1405-15. et al. Am J Clin Nutr 2000: 71:S292-9S. 11 What are these special FAs?? What is their role anyway? • LCPUFA are Essential Fatty acids and cannot be synthesized in the body and therefore they are required from the diet • They serve important physiological functions in the organism • NATO workshop: (1) have anti-inflammatory properties; (2) lower serum triglycerides and cholesterol; and (3) decrease thrombosis and platelet aggregation (J Nut, 89) • Grey matter expansion, cell membrane, and neurodevelopment LCPUFA: The argument • Several studies has suggested that human evolved on a diet with a Omega-6/Omega-3 ratio of approximately 1:1 • Today’s lifestyle and alimentation created an imbalance in the Omega-6/Omega-3 ratio however in current diet it ranges from 10:1 to 25:1 • This imbalance fuels the concerns that today’s diet may be insufficient to meet Omega-3 FA’s requirements and calls supplementation The argument: Pregnancy & meet the need? • Pregnancy: Increased demand for DHA • DHA: Preferentially transported to the infant during 3rd trimester of gestation & coincides with later stages of brain & retinal maturation, WITH estimated 67–75 mg/day of DHA accumulated in utero at the same time • More demand: Expanded RBC mass, placenta, and basic needs (LOW dietary intake) • Supply: Maternal DHA intake Adaptive metabolic mechanisms(increased synthetic capacity to metabolise alpha LA to DHA Preferential use of the DHA stored in adipose tissue DHA saved from pregnancy amenorrhea AJCN, 00, 09, J Nutr, 01, 05, Placenta, 05, Pediatrics, 08 The evidence PTB & GA Neurodevelopment and growth IVF and others (maternal depression) DHA and PTB: Biological plausibility? • A high ratio of omega-6 to omega-3 fatty acids will result in increased proinflammatory eicosanoid production (ie,PGE2 & PGF2) • More DHA in diet: Reduction in the production of proinflammatory eicosanoids and increased production of prostacyclin (PGI2), which may promote myometrial relaxation • Omega-3 fatty acids downregulate the production of PGE2 & PGF2, and may thereby inhibit the parturition process Clinic ObGyn, 04, AJOG, 06 13 RCTs Dosing, sources, and means!! Test your info!! • Pregnant and lactating: Aim to achieve at least 200-300 mg DHA/day to support optimal visual and cognitive development in offspring • Women advised to achieve fish consumption equal to 200 mg/day DHA intake rather than merely relying on the number of servings of fish • A minority of women achieve this level of DHA: 1999-2002 National Health and Nutrition Examination (NHANES), mean DHA intake 73 mg/day among pregnant women, and 62 mg/day among childbearing age March of Dimes, 09, Br J Nut, 07 Global Recommendations France Japan 21 What happens with Iod in pregnancy? • During pregnancy, hormonal changes and metabolic demands result in significant changes in thyroid function • Increased need for iodine supply due to: (1) Increased production of TH & maintain euthyroidism, (2) Elevated renal clearance of iodine, and (3) the fetoplacental acquisition of maternal iodine and TH Best Pract Res Clin Endocrinol Metab , 04, Thyroid, 2000 ID & maternal neonatal child outcomes: Test your info! • 3rd cause of developmental problems in children • ID disorders: Range from mild to moderate to severe • Developmental quotient: Reduction in IQ scores to cretinism • Severe ID during pregnancy: Congenital hypothyroidism resulting in cretinism, an irreversible form of retarded growth and mental retardation Biological plausibility • MID during pregnancy: Hypothyroxinemia in the mother and/or elevated (TSH) levels in the fetus • Related to mild and subclinical cognitive and psychomotor deficits in neonates, infants and children (Journal of Trace Elements in Medicine and Biology, 13) • Before the fetal hypothalamic–pituitary–thyroid system becomes operative, maternal T4 transfer is crucial for the fetus • The fetal thyroid grows between 12 and 39 weeks of gestation, becomes active in the 2nd trimester where demand for Iodine before 12-14 weeks Now show them the evidence…Research & studies